BA
Catalysts
Key Risks
The Opportunity
Boeing makes roughly half of all large commercial airplanes in the world. It's essentially a two-company market - Boeing and Airbus - and no one else is close to breaking in. That duopoly is incredibly valuable and unlikely to change in our lifetimes. Airlines need new planes, there's a backlog of over $700 billion in orders, and global air travel keeps growing. On paper, this sounds like a fantastic business.
The problem is that Boeing has spent the last seven years in crisis. Two fatal crashes of its 737 MAX killed 346 people, led to a worldwide grounding, criminal charges, and billions in settlements. Since then, the company has lost over $36 billion, burned through its cash reserves, taken on massive debt, and diluted shareholders by issuing $21 billion in new stock. The company literally had negative net worth - it owed more than it owned - until late 2025. Today, the entire equity of this $185 billion company is just $6 billion.
The stock at $234 is pricing in a successful turnaround. Investors are betting that new CEO Kelly Ortberg can fix the quality problems, ramp up airplane production, get delayed planes certified, and start generating the kind of profits Boeing earned before the crisis. If that happens - if Boeing gets back to delivering 800+ planes a year at healthy margins - the stock could justify a much higher price. The $715 billion backlog means demand isn't the issue; customers are lined up for years.
But here's what could go wrong, and it's a long list. Boeing's defense division keeps losing money on fixed-price contracts - Air Force One alone just added another $280 million in overruns. The 777X, Boeing's next-generation widebody, has missed its certification target by seven years and counting. The CEO himself says margins will stay low until 2030. And all of this assumes no new safety incidents, no new strikes, no supply chain disruptions. Boeing has promised turnarounds before and failed to deliver. At the current price, you're paying for a recovery that may take another three to four years to materialize, on a balance sheet with almost no cushion if things go wrong again.
Our conservative analysis suggests the stock is worth roughly $170 per share - about 27% below where it trades today. The market is pricing in optimism that the financial data doesn't yet support. For patient investors, Boeing may eventually prove to be a good investment, but not at this price.
Breakdown
Boeing's balance sheet is among the most distressed of any large-cap industrial. As of Q2 2026, total assets stand at $165.87B against total liabilities of $159.75B, leaving just $6.12B in equity - or $7.59 per share against a stock price of $234.42 (P/B of 30.37x). This razor-thin equity buffer is the result of years of accumulated losses ($35B+ in net losses from 2019-2024) compounded by aggressive pre-crisis buybacks that destroyed the capital cushion.
Total debt (current + long-term) sits at $45.91B as of Q2 2026, down from $53.87B at year-end 2024 following the $21B equity raise [Seattle Times, 2025], but still enormous. The debt-to-equity ratio of 7.52x is dangerously high. Cash of $7.24B provides limited runway against $4.57B in near-term maturities.
The Spirit AeroSystems acquisition, completed in December 2025 for $4.7B [Spirit AeroSystems press release, January 2025], added goodwill and intangible assets whose realizable value depends entirely on Boeing's ability to execute its production ramp. Boeing's inventory and program accounting assets (deferred production costs on 737, 787, 777X programs) represent the bulk of the asset base - these are only worth face value if Boeing achieves projected delivery volumes and margins. The 777X alone carries a $4.9B charge [Simple Flying, 2026], signaling that book values on development programs may still overstate economic reality.
At estimated fair value, the balance sheet offers virtually no margin of safety - liquidation value is negative, and NAV per share is just $7.74.
Boeing's free cash flow picture is just barely turning positive after years of massive cash burn. TTM free cash flow is reported at negative $210M, though Q2 2026 generated $631M in operating free cash flow [TechTimes, July 28, 2026]. For context, Boeing burned through its cash reserves during 2019-2024, necessitating the $21B equity raise in late 2024 that diluted shares from roughly 600M to 788M - a 31% dilution that permanently reduces per-share economics.
Capital allocation priorities are necessarily constrained: debt service on $46B in obligations dominates, leaving minimal room for growth investment or shareholder returns. The dividend was suspended in 2020 and the current yield of 0.4% with a 0% payout ratio suggests the reinstatement is token at best. Share buybacks, which totaled over $40B in the decade before the MAX crisis, are off the table indefinitely.
The company's cash flow channeling is almost entirely toward debt repayment and working capital needs. Maintenance capex for Boeing's manufacturing facilities is substantial, and the Spirit AeroSystems integration adds further capital demands. The positive trajectory is real - H1 2026 revenue of $46.8B is up from $42.2B in H1 2025 - but the path to sustainable positive FCF of $5B+ annually (needed to meaningfully delever) requires flawless execution on production ramps that Boeing has repeatedly failed to deliver.
Boeing's track record over the past seven years is one of the worst among major industrials. Revenue peaked at $101.13B in 2018 with operating income of $11.8B and EPS of $17.85. Since then, the trajectory has been catastrophic: operating losses in every year from 2019 through 2025 (-$2.66B, -$12.98B, -$3.36B, -$3.51B, -$775M, -$10.75B, -$5.39B respectively). Cumulative net losses from 2019-2024 exceeded $36B.
The 2025 result showed revenue recovering to $89.46B with net income of $2.24B, but this was heavily distorted by Q4 2025's $8.22B net income - likely driven by one-time items related to the Spirit acquisition. Quarterly earnings have been wildly inconsistent: Q3 2025 posted a $5.34B loss followed by the $8.22B Q4 gain, then Q1 2026 at roughly breakeven and Q2 2026 at a $428M loss. Management has consistently missed its own timelines - the 777X was originally targeted for 2020 delivery, now pushed past 2027 [Bolt Flight, 2026].
The MAX 7 and MAX 10 variants, critical for narrowbody competitiveness, still lack certification with deliveries now expected in 2027 [Leeham News, July 28, 2026]. Defense programs have been serial destroyers of value, with KC-46, VC-25B, and T-7A collectively consuming billions in overrun charges. The earnings call history shows alternating beats and misses with no discernible trend toward reliability.
Gross margins remain below 5% versus the 19.4% achieved in 2018.
Analyst consensus projects an 87.4% five-year EPS growth rate, but this figure is misleading - it reflects recovery from a near-zero base ($2.64 TTM EPS) rather than genuine business expansion. The forward P/E of 53.18 implies roughly $4.41 in forward EPS, suggesting analysts expect only modest near-term improvement. CEO Ortberg has explicitly stated margins will remain low until 2030 [Leeham News, July 28, 2026], tempering expectations for rapid profit recovery.
The bull case rests on Boeing's $715B record backlog [Boeing Q2 2026 results] and the aerospace industry's structural undersupply - 5,284 fewer aircraft delivered 2019-2026 versus pre-pandemic projections, creating an 11+ year combined backlog [Bain & Company, 2026]. If Boeing can ramp 737 production to 38-42/month and begin 777X deliveries, revenue could approach $95-100B by 2028-2029. However, even at improved but still below-peak margins of 6-8% operating, that translates to $5.7-8.0B in operating income, or roughly $3.5-5.5B in net income, or $4.44-$6.98 EPS on 788M diluted shares.
At a 20-25x P/E (appropriate for a cyclical industrial with massive debt), that implies $89-175 per share in 2028-2029 value, discounted back. The PEG ratio of 0.61 appears attractive, but the growth rate denominator is artificially inflated. Sustainable long-term EPS growth, once the base normalizes around $8-10, is likely 5-8% - typical for mature aerospace.
The key assumption driving any bullish case is that Boeing can execute, and the last seven years provide little evidence that it can.
Boeing occupies one half of the most durable duopoly in global manufacturing. The commercial aircraft market is effectively a two-player game between Boeing and Airbus, with combined backlogs of 15,461 aircraft representing 11+ years of production [Bain & Company, 2026]. Barriers to entry are immense: certification timelines measured in decades, supply chain complexity involving thousands of specialized suppliers, and customer switching costs running into billions (pilot training, maintenance infrastructure, parts inventories).
COMAC's C919 remains a distant regional competitor with no credible path to displacing either Western OEM globally within a decade. Boeing's defense franchise adds further moat via classified programs, security clearances, and long-term government relationships. However, the moat is narrowing relative to Airbus: the A320neo family now holds roughly 60% narrowbody market share [Stratview Research, 2026], the A350 is capturing widebody orders while the 777X remains uncertified, and Boeing's quality and safety reputation - the ultimate intangible asset for an aircraft manufacturer - has been severely damaged.
The moat remains wide due to structural factors, but the trend is clearly erosion on the commercial side.
CEO Kelly Ortberg, appointed August 2024 [CompositesWorld, 2024], represents Boeing's fourth CEO since 2019 and brings 35 years of aerospace experience. His priorities - stabilizing operations, executing programs, cultural change, and building Boeing's future - are appropriate but largely aspirational at this stage. The elimination of the COO role signals structural simplification.
CFO Jay Malave assumed his role in August 2025 [Boeing SEC Form 8-K, June 2025], meaning the C-suite is relatively new and unproven as a team. Insider ownership at 0.11% is negligible, providing minimal alignment with shareholders - though Director Bradley Tilden's $299K open-market purchase in May 2026 is a modest positive signal. Institutional ownership at 75.9% with net positive transactions (+0.82%) suggests professional investors are cautiously constructive.
The capital allocation track record over the past decade is poor: pre-crisis buybacks destroyed the equity cushion that would have provided resilience, and post-crisis management has been reactive rather than strategic. Boeing's conviction as a felon [CNBC, November 6, 2025] reflects governance failures that predated the current team. I cannot assess Ortberg's personal integrity or cultural change efforts - only the measurable outcomes, which remain insufficient thus far.
Risk is elevated across multiple dimensions. Legal exposure remains material: the securities class action covering 2021-2024 stock acquisitions gained partial class certification in March 2026 [Labaton Keller Sucharow, 2026; Bloomberg Law, 2026], with potential damages in the billions. Boeing's guilty plea to conspiracy to defraud the United States creates ongoing regulatory and reputational risk [CNBC, November 6, 2025].
Execution risk is the dominant concern - every major program (737 MAX production ramp, 777X certification, MAX 7/10 certification, defense fixed-price contracts) carries significant timeline and cost risk. The FAA's heightened oversight regime effectively caps Boeing's production flexibility [AerospaceGlobalNews, 2026]. Financial risk stems from the $46B debt load against thin equity - a prolonged production disruption (strike, quality incident, supply chain failure) could trigger a liquidity crisis.
Defense program losses continue to bleed value: VC-25B added another $280M overrun in Q2 2026 alone [Forbes, July 28, 2026]. Tariff uncertainty poses a secondary risk, with some airlines reconsidering U.S. manufacturer commitments [Airways Magazine, 2026]. Customer concentration risk exists in defense (U.S. government) and commercial (top airlines represent outsized backlog shares).
The short float at 1.73% suggests limited bearish conviction, but this may reflect the difficulty of shorting a turnaround story rather than confidence in the upside.
The commercial aerospace industry is in a strong cyclical position. Global passenger traffic is projected to reach a record 5.2 billion passengers in 2026 [Precision Aviation Group, 2026], and the commercial aircraft market is growing at approximately 4.3% CAGR [Research and Markets, 2026; Coherent Market Insights, 2026]. The post-pandemic delivery deficit of 5,284 aircraft creates a secular demand tailwind that benefits both OEMs [Bain & Company, 2026].
Boeing's $715B backlog is a record and ensures demand visibility well into the 2030s [Boeing Q2 2026 results]. However, Boeing is clearly the weaker half of the duopoly: Airbus delivered 793 aircraft in 2025 versus Boeing's 600, and Airbus slightly outperformed on narrowbody orders (544 vs 461) [Simple Flying, 2026]. Institutional positioning is constructive - Vanguard holds 9.06% ($16.3B), BlackRock 6.78% ($12.4B) [Stock Titan / SEC Schedule 13G, 2026; Yahoo Finance, 2026].
Analyst consensus at 1.67 (between strong buy and buy) with a $271 target reflects a market that is pricing in recovery execution. Social sentiment scores averaging 4.3/5 suggest retail enthusiasm. No formal takeover bid has been reported, though Forbes noted activists and Warren Buffett were 'circling' in early 2025 [Forbes, January 19, 2025].
The industry is favorable, but Boeing-specific execution challenges offset the tailwind.